Rob Kessels

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

Maartje W. Rohaan, Troels Holz Borch, Joost H. van den Berg et al. · New England Journal of Medicine · 2022 · 536 citations · Full text

Medicine, Immunology, Oncology +17

Efficacy and Safety of On-Demand Use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical Trials

Adriaan Tuiten, Kim van Rooij, Jos Bloemers et al. · The Journal of Sexual Medicine · 2017 · 44 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study

Anna van der Voort, Fleur M. Louis, Mette S. van Ramshorst et al. · The Lancet Oncology · 2024 · 43 citations · Full text

Medicine, Oncology, Radiology +14

The dosimetric and clinical advantages of the GTV-CTV-PTV margins reduction by 6 mm in head and neck squamous cell carcinoma: Significant acute and late toxicity reduction

Abrahim Al‐Mamgani, Rob Kessels, Tomas Janssen et al. · Radiotherapy and Oncology · 2022 · 31 citations · Full text

Medicine, Oncology, Radiation Oncology +12

Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/IIa trial

Jessica S.W. Borgers, Femke Burgers, Elisabeth M. Terveer et al. · BMC Cancer · 2022 · 26 citations · Full text

Life Sciences, Immunology, Oncology +17